Leena Peltonen-Palotie

Leena Peltonen-Palotie (16 June 1952 – 11 March 2010) was a Finnish geneticist who contributed to the identification of 15 genes for Finnish heritage diseases, including arterial hypertension, schizophrenia, lactose intolerance, arthrosis and multiple sclerosis. She was considered one of the world's leading molecular geneticists.
Biography.
Peltonen-Palotie was born in Helsinki, but her family moved to Oulu when she was just five years old. She completed her secondary education at the Finnish Co-educational Lycée of Oulu, graduating in 1971. Peltonen-Palotie went on to study medicine, receiving her Licentiate of Medicine degree in 1976, and completed her doctoral thesis at the University of Oulu in 1978.
Peltonen-Palotie worked at the National Public Health Institute of Finland 1987–1998. From 1998 to 2002 she helped found the UCLA Department of Human Genetics. She had a professorial position in the Academy of Finland since 2003. In April 2005 Peltonen-Palotie was employed in the University of Helsinki and the National Public Health Institute of Finland. She was also the project director in the EU project GenomEUtwin that was formed to define and characterize the genetic components in the background of different diseases. In 2004 she became a member of the Board of Directors of Orion Corporation, the largest Finnish pharmaceutical company. In September 2007, Peltonen-Palotie joined the Wellcome Trust Sanger Institute as the head of Human Genetics. She also headed research groups at the Broad Institute of MIT and Harvard University.
Peltonen-Palotie published over 500 research articles and almost 80 invited articles, and mentored over 70 PhD students in her career. 
She died on 11 March 2010 from bone cancer.